To rebut the concerns about histotripsy potentially affecting...

To rebut the concerns about histotripsy potentially affecting OncoSil Medical's (ASX: OSL) market and investment value, consider the following points:

While histotripsy, an innovative technology using high-powered ultrasound waves to destroy liver tumours, shows promise, it's important to remember that cancer treatments are often highly specific. The effectiveness of a treatment for one type of cancer (like liver cancer) doesn't automatically translate to effectiveness in another (like pancreatic cancer).

Histotripsy is still in its early stages, particularly for cancers beyond liver tumours. The journey from initial FDA approval to widespread clinical adoption, especially across various cancer types, is long and uncertain. This means that existing treatments, like OncoSil Medical’s product, will continue to play a critical role in cancer treatment for the foreseeable future.

The introduction of new treatments like histotripsy can actually be complementary rather than competitive. The complexity of cancer treatment often requires a multi-modal approach. It's possible that treatments like OncoSil's brachytherapy and histotripsy could be used in conjunction to improve patient outcomes.

The market for cancer treatments is vast and diverse. The success of one treatment modality does not necessarily eclipse the relevance or demand for others. There is often room for multiple players, especially in fields as complex and varied as cancer treatment.

OncoSil Medical, like other biotech companies, is likely continuously working on advancing their technologies and exploring new applications. This adaptability and commitment to innovation can help mitigate the impact of emerging competing technologies.

While histotripsy represents an exciting development in cancer treatment, its impact on OncoSil Medical’s market position should be viewed in the context of the broader and ever-evolving landscape of cancer therapeutics. The field is large enough to accommodate multiple treatment modalities, and innovations can often be complementary rather than purely competitive. Do your own research.